Hiroki Yoshioka

16PUBLICATIONS
18CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionPacific Peoples cultural determinants of healthMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 04, 2026
1-Palmitoyl-4-piperidinopiperidine exhibits anticancer effects in murine triple-negative breast cancer EO771 cells associated with STAT3 signaling suppression.

|Jun 28, 2026
Circadian Dependence of Subacute Renal Toxicity of Cadmium.

|Apr 08, 2026
Time-of-Day Differences in the Plasma N-Glycome of Normal and Obese Mice and the Effects of Dapagliflozin Administered in the Morning or at Night.

Yurika Ozawa, Fumi Muramoto, Hana Senda

|Jan 28, 2026
Diurnal variation of cisplatin-induced anti-tumor effect and renal toxicity in mice bearing human colon cancer cells.

Hiroki Yoshioka, Yurie Mikami, Kohei Matsushita

|Apr 12, 2025
Sasa veitchii Extract Mitigates Mycophenolate Mofetil-Induced Human Palatal Cell Proliferation Inhibition by Downregulating microRNA-4680-3p.

Hanane Horita, Yosuke Tsukiboshi, Kenichi Ogata

|Feb 25, 2025
Cleft Palate Induced by Mycophenolate Mofetil Is Associated with miR-4680-3p and let-7c-5p in Human Palate Cells.

Hiroki Yoshioka, Hanane Horita, Yosuke Tsukiboshi

Pageof 3

Frequent Collaborators

6 joint publications

Junichi Iwata

4 joint publications

Akiko Suzuki

3 joint publications

Kenichi Ogata

2 joint publications

Zhongming Zhao